Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

Scientists believe they have discovered how the cheap painkiller aspirin can stop cancers spreading. In animal experiments they showed the drug enhanced the ability of the immune system to fight back.

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ...

There are some risks associated with taking an aspirin regimen, and people should speak with their doctors before taking the drugs for colorectal cancer prevention. A tool for preventing ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

Rise in prevalence of cardiovascular disease and rise in demand for pain management solutions are major factors that drive the growth of the global aspirin drugs market. However, availability of ...

Rise in prevalence of cardiovascular diseases (CVDS), expanding applications in pain management & fever reduction, and government & healthcare initiatives promoting preventive medicine drive the ...